L740-0323 Screening compound: 4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide

L740-0323 Screening compound: 4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide
L740-0323 Screening compound: 4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L740-0323
4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L740-0323

Molecular Formula

C25H29ClN4O3 (C25 H29 ClN4 O3)

Compound Name

4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide

IUPAC name

4-[2-(4-benzylpiperidin-1-yl)-2-oxoethyl]-N-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide

SMILES

O=C(CN(CCN(C1)C(Nc(cc2)ccc2Cl)=O)C1=O)N1CCC(Cc2ccccc2)CC1

InChI

InChI=1S/C25H29ClN4O3/c26-21-6-8-22(9-7-21)27-25(33)30-15-14-29(24(32)18-30)17-23(31)28-12-10-20(11-13-28)16-19-4-2-1-3-5-19/h1-9,20H,10-18H2,(H,27,33)

InChI Key

ZBRBKQRRPIDVNJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27473361

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.98

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.460

Distribution Coefficient, logD

3.460

Water Solubility, LogSw

-3.87

Polar Surface Area

58.466

Acid Dissociation Constant (pKa)

12.24

Base Dissociation Constant (pKb)

4.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

L740-0323 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with L740-0323 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L740-0323?
Check Price and Availability of L740-0323, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L740-0323 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L740-0323
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L740-0323
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L740-0323 available by request